Evidence map›Paper›PMID 41939470›Full record

ReviewFrontiers in oncology2026

Artificial intelligence and its application in early oral cancer screening: a systematic review.

Weibo Huang

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Weibo HuangSchool & Hospital of Stomatology, Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral cancer is a globally prevalent and life-threatening malignancy, where early detection can significantly improve prognosis and reduce mortality. Traditional screening methods are often limited by operator dependence, invasiveness, and high costs, leading to frequent late diagnoses. This systematic review aims to evaluate the current application of artificial intelligence (AI) technology in the early diagnosis and risk prediction of oral cancer, with a focus on diagnostic accuracy, methodological diversity, and clinical translatability.

methodsWe conducted a systematic search across five databases (PubMed, Embase, Cochrane Library, Web of Science, and Scopus), incorporating 63 high-quality studies. The analysis was performed at two levels: data input modalities and the evolution of AI algorithms. Study selection, data extraction, and quality assessment followed standard systematic review protocols.

resultsAI models demonstrated high sensitivity and specificity in detecting early oral lesions and differentiating precancerous lesions, showing a trend toward multimodal fusion, lightweight, and high-performance development. However, most studies faced challenges such as insufficient sample sizes, limited external validation, and poor model interpretability.

conclusionAI holds significant potential for improving early oral cancer screening. To fully realize its clinical value, it is essential to establish large-scale multicenter datasets, conduct rigorous prospective validation, enhance model transparency, and address ethical and privacy concerns.

Indexed as

artificial intelligenceclinical photographydeep learningearly screeningmedical imaging

Identifiers

PMID41939470
PMCPMC13046525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.